Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 102.45B | 109.20B | 104.60B | 90.64B | 73.59B | 74.15B |
Gross Profit | 16.06B | 16.87B | 16.08B | 13.04B | 12.07B | 11.81B |
EBITDA | 12.21B | 14.01B | 13.63B | 9.46B | 8.99B | 9.22B |
Net Income | 5.94B | 5.94B | 5.89B | 5.37B | 3.87B | 3.70B |
Balance Sheet | ||||||
Total Assets | 109.29B | 115.53B | 106.81B | 100.36B | 89.20B | 84.87B |
Cash, Cash Equivalents and Short-Term Investments | 44.58B | 47.58B | 43.29B | 39.47B | 34.82B | 32.68B |
Total Debt | 0.00 | 215.00M | 105.00M | 1.63B | 1.62B | 1.62B |
Total Liabilities | 20.97B | 23.26B | 20.75B | 21.33B | 17.18B | 17.38B |
Stockholders Equity | 85.37B | 88.92B | 82.98B | 76.11B | 69.69B | 65.00B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.61B | 8.21B | 4.86B | 3.33B | 4.89B |
Operating Cash Flow | 0.00 | 9.84B | 11.92B | 7.77B | 6.03B | 8.38B |
Investing Cash Flow | 0.00 | -4.50B | -2.97B | -2.62B | -2.62B | -2.56B |
Financing Cash Flow | 0.00 | -3.05B | -6.17B | -2.26B | -2.22B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥75.24B | 6.05 | 5.65% | -1.56% | -5.87% | ||
79 Outperform | ¥69.93B | 11.95 | 3.91% | 4.40% | 3.95% | ||
75 Outperform | ¥81.42B | 5.85 | 3.85% | -0.59% | -20.66% | ||
70 Outperform | ¥71.20B | 11.46 | 0.75% | -11.15% | -51.63% | ||
69 Neutral | ¥63.68B | 7.39 | 5.13% | -0.69% | 8.45% | ||
63 Neutral | ¥57.71B | 33.50 | 5.96% | -1.86% | -55.23% | ||
62 Neutral | $16.65B | 11.30 | -7.38% | 3.01% | 1.59% | -23.30% |